Cintas Corporation CTAS
Verdict: Sell. Fair value $105 against a price of $185 on 6 Jan 2026, 43% below the price.
In plain words
The case for: Wide competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Macro headwinds could impact growth. Valuation multiple compression risk.
Main risks
- Significant data discrepancy: TTM Revenue ($7.99B) is inexplicably lower than the last three reported annual revenues ($8.82B, $9.60B, $10.34B), suggesting a potential data error or a sharp, un-explained recent business decline.
- Decelerating revenue growth: Annual growth has slowed from 12.4% (FY23) to a projected 7.7% (FY25), indicating potential market saturation or increased competition.
- Questionable incremental returns: The estimated 3-year ROIIC of ~11.6% is solid but significantly lower than the current ROIC of ~19.5%, suggesting that new investments are generating lower returns than the legacy asset base.
- Valuation prices in optimistic scenario (limited margin for error)
- Overhang: The ongoing 'battle for route dominance' related to Cintas's $5.2B bid for UniFirst introd...
- Market volatility